Real-Time Cellular Uptake Data for Antimicrobials & Small Molecules
Streamline hit-to-lead selection with quantitative absorption data in human and bacterial cells. Cut failures and speed up discovery.
Fast
Time-efficient results for faster go/no-go decisions.
High Throughput
Screen thousands of compounds with standardised metrics.
Versatile
Works in both human and bacterial cells, ideal for antimicrobial research.
About Us
Developing Better Tools for Early Drug Discovery
DrugUptech was founded to address one of the biggest problems in early-stage R&D: understanding whether compounds actually reach their cellular targets.
Backed by the University of Kent, our team of scientists and innovators has built a new screening system to help researchers reduce failure rates and accelerate the drug discovery timeline – especially for antibiotics, CNS drugs, and hard-to-penetrate targets.
Time & Resource Efficient
High Throughput
Real-time, quantitative data on compound permeability across diverse cell types.
Expand antimicrobial research with high-throughput, cell-based assays.
Power smarter AI-driven screening with reliable uptake metrics.
Our Technology
Our Drug Uptake & Permeation Screening Platform
Many promising compounds fail not because they’re inactive – but because they don’t reach their target. Traditional uptake and permeability methods are slow, expensive, and not designed for antimicrobial research.
Our solution offers:
Real-time compound uptake tracking
Broad compatibility with human, bacterial, and barrier cell models
Kinetic data to inform formulation and optimisation
Simple, scalable protocols
We’re collaborating with pharma partners to develop case studies.
Drug Discovery
The drug discovery process is slow and expensive. Our screening platform reduces cost and time by enabling rapid high-throughput assessment of drug uptake, permeation and efflux.
Monitoring Drug Uptake
Our cell-based assay monitors drug uptake in any cell line (including bacteria) or permeation through cellular barriers, including the Blood brain barrier.
Antimicrobial Research
Our platform enables the study of uptake, permeation, and efflux kinetics of antimicrobials in bacteria cells.
Get In Touch
Be part of our early access programme and help shape the future of smart permeability testing.
Email us at:
j.l.ortega-roldan@kent.ac.uk